Vestor Capital, LLC Exact Sciences Corp Transaction History

Vestor Capital, LLC

$1.27 Billion
Q3 2024

A detailed history of Vestor Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Vestor Capital, LLC holds 675 shares of EXAS stock, worth $47,553. This represents 0.0% of its overall portfolio holdings.

Number of Shares

675

Holding current value

$47,553

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$42.43 - $70.83 $28,640 - $47,810	675 New	675 $46,000
Q2 2023 Aug 21, 2023	SELL	$62.68 - $95.05 $845,615 - $1.28 Million	-13,491 Reduced 95.24%	675 $63,000
Q2 2023 Aug 09, 2023	BUY	$62.68 - $95.05 $845,615 - $1.28 Million	13,491 Added 1998.67%	14,166 $1.91 Million
Q1 2023 May 10, 2023	SELL	$47.19 - $70.77 $660,188 - $990,072	-13,990 Reduced 95.4%	675 $46,000
Q1 2023 Apr 26, 2023	BUY	$47.19 - $70.77 $692,041 - $1.04 Million	14,665 New	14,665 $3.57 Million
Q2 2022 Aug 10, 2022	SELL	$35.61 - $76.23 $41,841 - $89,570	-1,175 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$72.5 - $100.68 $36,250 - $50,340	500 Added 74.07%	1,175 $91,000
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $67,236 - $95,931	675 New	675 $89,000

Others Institutions Holding EXAS

# of Institutions

637

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

Vanguard Group Inc Valley Forge, PA

18.2M
Shares

$1.28 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

16.5M
Shares

$1.16 Billion
0.12% of portfolio
Wellington Management Group LLP Boston, MA

14.8M
Shares

$1.04 Billion
0.11% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$850 Million
0.01% of portfolio
State Street Corp Boston, MA

8.21M
Shares

$578 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestor Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vestor Capital, LLC with notifications on news.

Account